| Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells SB Yong, JY Chung, Y Song, J Kim, S Ra, YH Kim Biomaterials 219, 119401, 2019 | 54 | 2019 |
| Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy J Kim, J Hong, J Lee, SF Lahiji, YH Kim Journal of Controlled Release 332, 109-126, 2021 | 41 | 2021 |
| Dissolvable Self‐Locking Microneedle Patches Integrated with Immunomodulators for Cancer Immunotherapy SH Joo, J Kim, J Hong, S Fakhraei Lahiji, YH Kim Advanced Materials 35 (10), 2209966, 2023 | 29 | 2023 |
| Heme Oxygenase 1‐Targeted Hybrid Nanoparticle for Chemo‐and Immuno‐Combination Therapy in Acute Myelogenous Leukemia SB Yong, J Kim, JY Chung, S Ra, SS Kim, YH Kim Advanced Science 7 (13), 2000487, 2020 | 20 | 2020 |
| Engineering TGF-β inhibitor-encapsulated macrophage-inspired multi-functional nanoparticles for combination cancer immunotherapy J Kim, M Kim, SB Yong, H Han, S Kang, SF Lahiji, S Kim, J Hong, Y Seo, ... Biomaterials Research 27 (1), 136, 2023 | 6 | 2023 |
| Dual Adjuvant‐Loaded Peptide Antigen Self‐Assembly Potentiates Dendritic Cell‐Mediated Tumor Immunotherapy J Kim, S Kang, J Kim, SB Yong, SF Lahiji, YH Kim Advanced Science, 2403663, 2024 | | 2024 |
Shayan F. LahijiResearch Professor在 hanyang.ac.kr 的电子邮件经过验证
Shayan F. LahijiResearch Professor在 hanyang.ac.kr 的电子邮件经过验证
Juhyeong HongDepartment of Bioengineering, Hanyang University, Seoul, Korea在 hanyang.ac.kr 的电子邮件经过验证